VELOCITY: An Anthrax Vaccine Clinical Study
Clinical trial NCT03877926 · COMPLETED
Trial details
- NCT number
- NCT03877926
- Sponsor
- Emergent BioSolutions
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-11
- Primary completion
- 2020-08-06
- Enrollment
- 3689
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.